Mutation-targeted Bladder Cancer Drug Found Under-used
," said study lead author Vivek Nimgaonkar, a Perelman School of Medicine student and graduate associate with the Penn Center for Precision Medicine.
"Our…
Browsing Tag
erdafitinib
Erdafitinib Continues to Show Efficacy in Urothelial Carcinoma
The pan-FGFR tyrosine kinase inhibitor erdafitinib (Balversa) was active and safe in patients…